Enliven Therapeutics, Inc.
ELVN
$20.63
$0.3051.50%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 69.40% | -7.62% | 7.40% | -6.58% | -2.53% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 7.47% | 2.81% | -9.32% | -10.10% | -14.43% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | 0.00% | 0.00% | -99.46% |
Total Current Assets | 68.40% | -7.48% | 7.11% | -6.64% | -5.66% |
|
|||||
Total Current Assets | 68.40% | -7.48% | 7.11% | -6.64% | -5.66% |
Net Property, Plant & Equipment | -2.75% | 130.35% | -27.30% | -20.35% | -14.39% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.58% | 0.31% | -8.05% | -3.96% | 74.58% |
Total Assets | 66.54% | -7.12% | 6.66% | -6.61% | -4.59% |
|
|||||
Total Accounts Payable | 50.51% | 16.39% | 31.70% | -5.91% | -60.29% |
Total Accrued Expenses | 4.39% | -17.19% | -8.52% | 38.24% | -2.10% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 3.01% | -- | -- | -49.70% | -32.94% |
Total Finance Division Other Current Liabilities | -56.85% | -28.43% | -5.56% | -97.72% | -9.14% |
Total Other Current Liabilities | -56.85% | -28.43% | -5.56% | -97.72% | -9.14% |
Total Current Liabilities | 8.87% | -12.21% | -6.53% | -22.97% | -11.69% |
|
|||||
Total Current Liabilities | 8.87% | -12.21% | -6.53% | -22.97% | -11.69% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -32.45% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -82.35% |
Total Liabilities | 7.99% | -10.31% | -6.53% | -22.99% | -11.79% |
|
|||||
Common Stock & APIC | 40.27% | 1.28% | 8.81% | 1.24% | 1.47% |
Retained Earnings | -9.31% | -11.72% | -10.52% | -11.75% | -11.26% |
Treasury Stock & Other | -1,006.25% | -129.09% | -77.27% | 274.10% | -162.26% |
Total Common Equity | 69.43% | -6.95% | 7.43% | -5.42% | -4.02% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 69.43% | -6.95% | 7.43% | -5.42% | -4.02% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 69.43% | -6.95% | 7.43% | -5.42% | -4.02% |
|